Statistics for Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

Total visits

views
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer 251

Total visits per month

views
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0

File Visits

views
JCO.2017.72.4138.pdf 220

Top country views

views
United States 190
Germany 15
Sweden 7
China 5
Ukraine 5
Canada 2
United Kingdom 1
Greece 1
Iran 1
Malaysia 1
Russia 1

Top city views

views
Wilmington 55
Fairfield 25
Houston 16
Kiez 11
White Plains 10
Ann Arbor 7
Jacksonville 7
Cambridge 6
Indianapolis 6
Stockholm 6
Kiev 5
Gunzenhausen 4
Ling 4
Seattle 3
Washington 3
Brooklyn 2
Lake Mary 2
Toronto 2
Beijing 1
Chestertown 1
Chicago 1
Monmouth Junction 1
Mountain View 1
Philadelphia 1
Péfki 1
Saint Petersburg 1
San Francisco 1
Scottsdale 1
Seremban 1
Tehran 1